SequelSEC

GOLDENWELL BIOTECH, INC. GWLL

Food and Kindred Products · CIK 0001800373 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$55
Fiscal year ended 2026-06-30
Operating income
-$114.80K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$14.52MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.15Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue264000.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Food and Kindred Products filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Net margin-539038.2%0th
Operating margin-206047.3%0th
Revenue YoY growth-60.4%0th
Gross margin21.8%38th

GOLDENWELL BIOTECH, INC. (GWLL) reported revenue of $55 and net income of -$282.12K for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from GOLDENWELL BIOTECH, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Food and Kindred Products.

Income

GOLDENWELL BIOTECH, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$55
Cost of revenue$43
Gross profit$12
Operating income-$114.80K
Net income-$282.12K
Research & developmentUnavailable
Weighted-average diluted sharesshares 393.43M
Pretax incomeUnavailable
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$114.81K
Selling & marketingUnavailable

Balance

GOLDENWELL BIOTECH, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$28.98K
Current assetsUnavailable
Total liabilities$427.17K
Current liabilities$100.00K
Total equity incl. NCI-$398.20K
Temporary (mezzanine) equityUnavailable
Inventory$0
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$0

Cash flow

GOLDENWELL BIOTECH, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$110.36K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$45.00K
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

GOLDENWELL BIOTECH, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin21.8%
Operating margin-208729.1%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratioUnavailable
Revenue YoY growthUnavailable
Net margin-512940.0%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GWLL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-K · Filed 2026-07-01View SEC filing
10-Q · Filed 2026-07-01View SEC filing
10-Q/A · Filed 2026-06-29View SEC filing
10-Q/A · Filed 2026-06-26View SEC filing
10-Q/A · Filed 2026-06-26View SEC filing

Companies in the same industry

BGS BOF BRBR BRLS BYND CAG CPB FLO HAIN LSF MDLZ OFRM

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.